Author

M. Papaioannou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Chaidos· 1 shared A. Dutta· 1 shared A. Karadimitris· 1 shared A. Katsarou· 1 shared B. Berrios· 1 shared D. Heilpern-Mallory· 1 shared D. Huynh· 1 shared E. D. Lightbody· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chaidos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 1, 2023

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

R. Sklavenitis-Pistofidis, E. D. Lightbody, M. Reidy…·S. Manier

DOI 10.1101/2023.08.01.551480

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 11, 2020

Over-accessible chromatin links myeloma initiating genetic events to oncogenic transcriptomes and aberrant transcription factor regulatory networks

J. Alvarez-Benayas, A. Katsarou, N. Trasanidis…·A. Karadimitris

The paper links myeloma initiating genetic events to chromatin accessibility and oncogenic transcriptomes, identifying critical enhancers regulating CCND2 expression.

DOI 10.1101/2020.06.11.140855

𝕏 PostBluesky